Edition:
United Kingdom

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

3.54USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$3.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,575
52-wk High
$6.43
52-wk Low
$1.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.062
Jun '18 0.00 -0.048
Mar '18 0.00 -0.064
FY 2017 Dec '17 0.00 0.212
Sep '17 0.00 -0.093
Jun '17 0.00 -0.041
Mar '17 0.00 -0.107
FY 2016 Dec '16 0.00 -2.762
Sep '16 0.00 -0.080
Jun '16 0.00 -0.137
Mar '16 0.00 -0.173
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Dec-18 1 -0.08 -0.08 -0.08 --
Quarter Ending Mar-19 1 -0.08 -0.08 -0.08 --
Year Ending Dec-18 1 -0.25 -0.25 -0.25 --
Year Ending Dec-19 1 -0.35 -0.35 -0.35 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta 1.93 0.91 0.91
Price to Sales (TTM) -- 4.00 6.22
Price to Book (MRQ) 1.74 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions 0.01 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -100.00 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 69.87 17.26 23.08
EPS (TTM) vs TTM 1 Yr. Ago -80.95 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate -38.41 15.23 14.58

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) 2.74 3.02 3.10
LT Debt to Equity (MRQ) 0.00 8.89 11.49
Total Debt to Equity (MRQ) 0.00 12.69 16.03
Interest Coverage (TTM) -- 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -196,820.59 18.41 13.16
Operating Margin (TTM) -- 14.42 6.07
Operating Margin - 5 Yr. Avg. -201,893.70 14.55 8.47
Pre-Tax Margin (TTM) -- 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -208,399.09 14.97 8.71
Net Profit Margin (TTM) -- 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -157,026.70 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 997,016,667 873,056,423
Net Income/Employee (TTM) -3,954,722 118,233,002 103,484,349
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) 0.00 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.33 11.98 11.45
Return on Assets - 5 Yr. Avg. -24.46 13.28 12.50
Return on Investment (TTM) -41.96 15.55 14.96
Return on Investment - 5 Yr. Avg. -25.93 17.28 16.23
Return on Equity (TTM) -52.95 16.92 16.52
Return on Equity - 5 Yr. Avg. -64.56 18.21 17.37
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -33.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cocrystal Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.23%
# of Holders: 32
Total Shares Held: 2,462,436
3 Mo. Net Change: 94,596
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 14
# Reduced Positions: 11
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.